Atrium Therapeutics, Inc. operates as a biopharmaceutical company that provides RNA therapeutics services to the heart to transform the standard of care for people living with cardiomyopathies. Its products pipeline includes two lead development candidates: ATR 1072 for PRKAG2 syndrome and ATR 1086 for PLN cardiomyopathy, both conditions are severe, life-threatening, rare autosomal dominant progressive cardiomyopathies with no approved treatment options and high unmet need. The company was founded on September 30, 2025 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Atrium Therapeutics Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Atrium Therapeutics Inc. market cap is $230.87M.
What is the 52-week high for Atrium Therapeutics Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Atrium Therapeutics Inc. 52 week high is $16.77 as of April 26, 2026.
What is the 52-week low for Atrium Therapeutics Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Atrium Therapeutics Inc. 52 week low is $11.95 as of April 26, 2026.
What is Atrium Therapeutics Inc. stock price today?
Atrium Therapeutics Inc. stock price today is $13.49.
What was Atrium Therapeutics Inc. stock price yesterday?
Atrium Therapeutics Inc. stock price yesterday was $13.85.
What is the Price-to-Book ratio of Atrium Therapeutics Inc.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Atrium Therapeutics Inc. P/B ratio is -3.6814.
What is the 50-day moving average of Atrium Therapeutics Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Atrium Therapeutics Inc. 50-day moving average is $13.92.